CORVEL CORP (CRVL) Stock Fundamental Analysis

NASDAQ:CRVL • US2210061097

47.27 USD
+0.72 (+1.55%)
At close: Feb 12, 2026
47.27 USD
0 (0%)
After Hours: 2/12/2026, 8:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 102 industry peers in the Health Care Providers & Services industry. CRVL gets an excellent profitability rating and is at the same time showing great financial health properties. CRVL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • CRVL had positive earnings in the past year.
  • In the past year CRVL had a positive cash flow from operations.
  • In the past 5 years CRVL has always been profitable.
  • Each year in the past 5 years CRVL had a positive operating cash flow.
CRVL Yearly Net Income VS EBIT VS OCF VS FCFCRVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1.2 Ratios

  • CRVL has a better Return On Assets (16.40%) than 99.02% of its industry peers.
  • CRVL has a better Return On Equity (28.14%) than 93.14% of its industry peers.
  • CRVL has a better Return On Invested Capital (27.56%) than 99.02% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRVL is significantly above the industry average of 9.04%.
Industry RankSector Rank
ROA 16.4%
ROE 28.14%
ROIC 27.56%
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
CRVL Yearly ROA, ROE, ROICCRVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of CRVL (11.23%) is better than 96.08% of its industry peers.
  • In the last couple of years the Profit Margin of CRVL has grown nicely.
  • The Operating Margin of CRVL (14.52%) is better than 86.27% of its industry peers.
  • CRVL's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CRVL (24.22%) is comparable to the rest of the industry.
  • CRVL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.52%
PM (TTM) 11.23%
GM 24.22%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
CRVL Yearly Profit, Operating, Gross MarginsCRVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CRVL is creating value.
  • The number of shares outstanding for CRVL remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CRVL has less shares outstanding
  • CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRVL Yearly Shares OutstandingCRVL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRVL Yearly Total Debt VS Total AssetsCRVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 10.00 indicates that CRVL is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 10.00, CRVL belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
  • CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10
ROIC/WACC3.12
WACC8.82%
CRVL Yearly LT Debt VS Equity VS FCFCRVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • CRVL has a Current Ratio of 1.85. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CRVL (1.85) is better than 75.49% of its industry peers.
  • A Quick Ratio of 1.85 indicates that CRVL should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.85, CRVL is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CRVL Yearly Current Assets VS Current LiabilitesCRVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

4

3. Growth

3.1 Past

  • CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.73%, which is quite impressive.
  • CRVL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.86% yearly.
  • Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 8.06% in the last year.
  • CRVL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.62% yearly.
EPS 1Y (TTM)21.73%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%2.17%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%3.36%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRVL Yearly Revenue VS EstimatesCRVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.17, which indicates a rather expensive current valuation of CRVL.
  • Compared to the rest of the industry, the Price/Earnings ratio of CRVL indicates a somewhat cheap valuation: CRVL is cheaper than 66.67% of the companies listed in the same industry.
  • CRVL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.17
Fwd PE N/A
CRVL Price Earnings VS Forward Price EarningsCRVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 67.65% of the companies in the same industry are more expensive than CRVL, based on the Enterprise Value to EBITDA ratio.
  • 60.78% of the companies in the same industry are more expensive than CRVL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.19
EV/EBITDA 12.82
CRVL Per share dataCRVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The excellent profitability rating of CRVL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.37
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for CRVL!.
Industry RankSector Rank
Dividend Yield 0%

CORVEL CORP

NASDAQ:CRVL (2/12/2026, 8:00:00 PM)

After market: 47.27 0 (0%)

47.27

+0.72 (+1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)05-20
Inst Owners54.85%
Inst Owner Change-2.21%
Ins Owners7.08%
Ins Owner Change-0.59%
Market Cap2.42B
Revenue(TTM)941.49M
Net Income(TTM)105.73M
Analysts0
Price TargetN/A
Short Float %2.26%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.17
Fwd PE N/A
P/S 2.57
P/FCF 23.19
P/OCF 16.22
P/B 6.44
P/tB 7.14
EV/EBITDA 12.82
EPS(TTM)2.04
EY4.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.04
FCFY4.31%
OCF(TTM)2.91
OCFY6.17%
SpS18.41
BVpS7.35
TBVpS6.62
PEG (NY)N/A
PEG (5Y)1.37
Graham Number18.36
Profitability
Industry RankSector Rank
ROA 16.4%
ROE 28.14%
ROCE 34.67%
ROIC 27.56%
ROICexc 66.14%
ROICexgc 85.44%
OM 14.52%
PM (TTM) 11.23%
GM 24.22%
FCFM 11.07%
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
ROICexc(3y)48.46%
ROICexc(5y)45.93%
ROICexgc(3y)62.9%
ROICexgc(5y)61.44%
ROCE(3y)35.98%
ROCE(5y)33.03%
ROICexgc growth 3Y4.75%
ROICexgc growth 5Y18.9%
ROICexc growth 3Y6.87%
ROICexc growth 5Y18.29%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
F-Score8
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 144.19%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 88.83%
Profit Quality 98.6%
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 10
F-Score8
WACC8.82%
ROIC/WACC3.12
Cap/Depr(3y)112.41%
Cap/Depr(5y)107.09%
Cap/Sales(3y)3.78%
Cap/Sales(5y)3.81%
Profit Quality(3y)90.78%
Profit Quality(5y)99.01%
High Growth Momentum
Growth
EPS 1Y (TTM)21.73%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%2.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%3.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.19%
EBIT growth 3Y12.65%
EBIT growth 5Y14.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.02%
FCF growth 3Y34.78%
FCF growth 5Y13.57%
OCF growth 1Y54.05%
OCF growth 3Y23.73%
OCF growth 5Y9.51%

CORVEL CORP / CRVL FAQ

What is the ChartMill fundamental rating of CORVEL CORP (CRVL) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CRVL.


Can you provide the valuation status for CORVEL CORP?

ChartMill assigns a valuation rating of 3 / 10 to CORVEL CORP (CRVL). This can be considered as Overvalued.


What is the profitability of CRVL stock?

CORVEL CORP (CRVL) has a profitability rating of 9 / 10.


Can you provide the financial health for CRVL stock?

The financial health rating of CORVEL CORP (CRVL) is 8 / 10.